Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 2,182 shares at $4.71 ($10K) on 2020-08-18, disclosed to the SEC on 2020-08-18.
Open-market sale of $10k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.64 | 984 | $5K | 44.4% |
| 2 | $4.86 | 454 | $2K | 21.5% |
| 3 | $4.71 | 744 | $4K | 34.1% |
| Total | $4.71 avg | 2,182 | $10K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $536K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |